Deals, Partnering

deCODE biostructures and Mitsubishi Tanabe initiate fragments of Life screening for fragment based lead discovery

Posted on 16 April 2009

Tags: ,

Successful completion of a research collaboration with the delivery of structure milestones to Mitsubishi Tanabe Pharma Corporation against an undisclosed novel target.

deCODE biostructures also announces the extension of this research collaboration to include fragment screening for hit identification using deCODE’s Fragments of Life™ library. The expansion of the collaboration provides Mitsubishi Tanabe Pharma Corporation access to deCODE’s unique hit identification program, computational chemistry, and high throughput crystallography resources. Further details and financial terms were not disclosed.

Print Friendly, PDF & Email

Leave a Reply